Loading...
OTCM
CGNSF
Market cap8kUSD
Nov 03, Last price  
0.00USD
Name

Cognetivity Neurosciences Ltd

Chart & Performance

D1W1MN
OTCM:CGNSF chart
P/E
P/S
0.27
EPS
Div Yield, %
Shrs. gr., 5y
18.88%
Rev. gr., 5y
%
Revenues
45k
000000045,366
Net income
-7m
L-43.37%
0-458,844-1,495,804-4,192,618-2,645,114-1,928,097-13,127,327-7,433,815
CFO
-6m
L+84.86%
0-326,183-859,730-3,489,220-1,856,603-1,958,741-3,214,534-5,942,352

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
IPO date
Mar 19, 2018
Employees
2,500
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑012022‑012021‑012020‑012019‑012018‑012017‑012016‑01
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT